Inventor · disambiguated record
Giuseppe Claudio Viscomi
Also filed as: VISCOMI GIUSEPPE C · VISCOMI GIUSEPPE CLAUDIO
45 granted patents·44 pending applications·639 citations·filing 1982–2022
98Inventor score
Files withALFA WASSERMANN SPA33ALFASIGMA SPA22VISCOMI GIUSEPPE CLAUDIO19SALIX PHARMACEUTICALS LTD3GUSHURST KAREN S2
Top patents by PatentIndex Score
89 records- 0197US8158781B2Polymorphic forms α, β and γ of rifaximinVISCOMI GIUSEPPE CLAUDIO·Filed 2011·Granted Apr 17, 2012·27 cites·8 claims
- 0297US7902206B2Polymorphic forms α, β and γ of rifaximinALFA WASSERMANN SPA·Filed 2008·Granted Mar 8, 2011·28 cites·57 claims
- 0397US7045620B2Polymorphous forms of rifaximin, processes for their production and use thereof in medicinal preparationsALFA WASSERMANN SPA·Filed 2003·Granted May 16, 2006·139 cites·20 claims
- 0496US8835452B2Polymorphic forms α, β and γ of rifaximinALFA WASSERMANN SPA·Filed 2012·Granted Sep 16, 2014·15 cites·21 claims
- 0596US8193196B2Polymorphous forms of rifaximin, processes for their production and use thereof in the medicinal preparationsVISCOMI GIUSEPPE CLAUDIO·Filed 2006·Granted Jun 5, 2012·40 cites·24 claims
- 0696US7915275B2Use of polymorphic forms of rifaximin for medical preparationsALFA WASSERMANN SPA·Filed 2007·Granted Mar 29, 2011·53 cites·30 claims
- 0796US7906542B2Pharmaceutical compositions comprising polymorphic forms α, β, and γ of rifaximinALFA WASSERMANN SPA·Filed 2008·Granted Mar 15, 2011·40 cites·25 claims
- 0895US8741904B2Polymorphous forms of rifaximin, processes for their production and use thereof in the medicinal preparationsALFA WASSERMANN SPA·Filed 2013·Granted Jun 3, 2014·20 cites·44 claims
- 0995US8518949B2Polymorphous forms of rifaximin, processes for their production and use thereof in the medicinal preparationsVISCOMI GIUSEPPE CLAUDIO·Filed 2012·Granted Aug 27, 2013·25 cites·21 claims
- 1095US8158644B2Pharmaceutical compositions comprising polymorphic forms α, β, and γ of rifaximinVISCOMI GIUSEPPE CLAUDIO·Filed 2011·Granted Apr 17, 2012·26 cites·20 claims
- 1195US7923553B2Processes for the production of polymorphic forms of rifaximinALFA WASSERMANN SPA·Filed 2008·Granted Apr 12, 2011·18 cites·46 claims
- 1294US9271968B2Polymorphous forms of rifaximin, processes for their production and use thereof in the medicinal preparationsALFA WASSERMANN SPA·Filed 2014·Granted Mar 1, 2016·14 cites·18 claims
- 1393US8853231B2Pharmaceutical compositions comprising polymorphic forms α, β, and γ of rifaximinALFA WASSERMANN SPA·Filed 2012·Granted Oct 7, 2014·15 cites·18 claims
- 1492US8173801B2Processes for the production of polymorphic forms of rifaximinVISCOMI GIUSEPPE CLAUDIO·Filed 2011·Granted May 8, 2012·14 cites·19 claims
- 1591US8217054B2Use of polyols to obtain stable polymorphous forms of rifaximinMAFFEI PAOLA·Filed 2007·Granted Jul 10, 2012·14 cites·30 claims
- 1690US8568782B2Gastroresistant pharmaceutical formulations containing rifaximinVISCOMI GIUSEPPE CLAUDIO·Filed 2006·Granted Oct 29, 2013·24 cites·30 claims
- 1790US8404704B2Use of polymorphic forms of rifaximin for medical preparationsVISCOMI GIUSEPPE CLAUDIO·Filed 2011·Granted Mar 26, 2013·12 cites·15 claims
- 1887US8748449B2Use of polyols to obtain stable polymorphous forms of rifaximinMAFFEI PAOLA·Filed 2012·Granted Jun 10, 2014·5 cites·36 claims
- 1984US9364467B2Rifaximin derivative and uses thereofSALIX PHARMACEUTICALS LTD·Filed 2015·Granted Jun 14, 2016·4 cites·8 claims
- 2083US9181274B2Forms of rifaximin and uses thereofGUSHURST KAREN S·Filed 2012·Granted Nov 10, 2015·4 cites·7 claims
- 2180US8748447B2Rifaximin powder, process for preparing the same and controlled release compositions containing said rifaximin useful for obtaining a long-lasting effectVISCOMI GIUSEPPE CLAUDIO·Filed 2011·Granted Jun 10, 2014·5 cites·12 claims
- 2280US2022119403A1Polymorphous forms of rifaximin, processes for their production and use thereof in the medicinal preparationsALFASIGMA SPA·Filed 2021·Application pending·0 cites
- 2380US2022127283A1Polymorphic forms alpha, beta and gamma of rifaximinALFASIGMA SPA·Filed 2022·Application pending·0 cites
- 2479US8318763B2Rifamycin derivativesVISCOMI GIUSEPPE CLAUDIO·Filed 2009·Granted Nov 27, 2012·5 cites·19 claims
- 2578US6866782B2Process for the purification of pharmacologically active proteins through cationic exchange chromatographyALFA WASSERMANN SPA·Filed 2002·Granted Mar 15, 2005·11 cites·7 claims
- 2677US9452157B2Pharmaceutical compositions comprising rifaximin and amino acids, preparation methods and use thereofALFA WASSERMANN SPA·Filed 2013·Granted Sep 27, 2016·5 cites·34 claims
- 2774US9725466B2Rifaximin derivative and uses thereofSALIX PHARMACEUTICALS INC·Filed 2016·Granted Aug 8, 2017·1 cites·20 claims
- 2873US10703763B2Polymorphous forms of rifaximin, processes for their production and use thereof in the medicinal preparationsALFASIGMA SPA·Filed 2019·Granted Jul 7, 2020·0 cites·9 claims
- 2973US9938298B2Solvated crystal form of rifaximin, production, compositions and uses thereofALFA WASSERMANN SPA·Filed 2015·Granted Apr 10, 2018·2 cites·10 claims
- 3073US4439360ARetro-inverso analogues of C-terminal penta and hexapeptides of Substance PANIC SPA·Filed 1982·Granted Mar 27, 1984·14 cites·20 claims
- 3173US2020339599A1Polymorphic forms alpha, beta and gamma of rifaximinALFASIGMA SPA·Filed 2020·Application pending·0 cites
- 3273US2019263829A1Polymorphic forms alpha, beta and gamma of rifaximinALFASIGMA SPA·Filed 2019·Application pending·0 cites
- 3373US2020277301A1Polymorphous forms of rifaximin, processes for their production and use thereof in the medicinal preparationsALFASIGMA SPA·Filed 2020·Application pending·0 cites
- 3473US2020339600A1Pharmaceutical compositions comprising polymorphic forms alpha, beta, and gamma of rifaximinALFASIGMA SPA·Filed 2020·Application pending·0 cites
- 3572US9035046B2Rifaximin derivative and uses thereofSALIX PHARMACEUTICALS LTD·Filed 2014·Granted May 19, 2015·1 cites·3 claims
- 3672US2015175627A1Polymorphic forms alpha, beta and gamma of rifaximinALFA WASSERMANN SPA·Filed 2014·Application pending·0 cites
- 3771US2019263830A1Pharmaceutical compositions comprising polymorphic forms alpha, beta, and gamma of rifaximinALFASIGMA SPA·Filed 2019·Application pending·0 cites
- 3870US9498442B2Rifaximin powder, process for preparing the same an controlled release compositions containing said rifaximin useful for obtaining a long-lasting effectALFA WASSERMANN SPA·Filed 2014·Granted Nov 22, 2016·1 cites·7 claims
- 3970US2019135831A1Polymorphic forms alpha, beta and gamma of rifaximinALFASIGMA SPA·Filed 2018·Application pending·0 cites
- 4068US9359357B2Forms of rifaximin and uses thereofGUSHURST KAREN S·Filed 2014·Granted Jun 7, 2016·0 cites·17 claims
- 4168US2015072002A1Use of polyols to obtain stable polymorphous forms of rifaxminALFA WASSERMANN SPA·Filed 2014·Application pending·0 cites
- 4268US2019135830A1Pharmaceutical compositions comprising polymorphic forms alpha, beta, and gamma of rifaximinALFASIGMA SPA·Filed 2018·Application pending·0 cites
- 4367US2018065987A1Polymorphic forms alpha, beta and gamma of rifaximinALFA WASSERMANN SPA·Filed 2017·Application pending·0 cites
- 4467US2008262024A1Rifaximin compositions and method of useVISCOMI GIUSEPPE CLAUDIO·Filed 2008·Application pending·0 cites
- 4567US2015182508A1Pharmaceutical compositions comprising polymorphic forms alpha, beta, and gamma of rifaximinALFA WASSERMANN SPA·Filed 2014·Application pending·0 cites
- 4666US2018291032A1Polymorphous forms of rifaximin, processes for their production and use thereof in the medicinal preparationsALFASIGMA SPA·Filed 2017·Application pending·0 cites
- 4766US2012203000A1Polymorphic forms alpha, beta and gamma of rifaximinVISCOMI GIUSEPPE CLAUDIO·Filed 2012·Application pending·0 cites
- 4866US2017210758A1Polymorphic forms alpha, beta and gamma of rifaximinALFA WASSERMANN SPA·Filed 2016·Application pending·0 cites
- 4965US10793925B2Lactobacillus paracasei for the production of conjugated linoleic acid, nutritional and pharmaceutical preparations containing it and uses thereofALFASIGMA SPA·Filed 2019·Granted Oct 6, 2020·0 cites·11 claims
- 5065US2018065988A1Pharmaceutical compositions comprising polymorphic forms alpha, beta, and gamma of rifaximinALFA WASSERMANN SPA·Filed 2017·Application pending·0 cites
Showing the top 50 of 89 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →